DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Fate Therapeutics, Inc. (FATE)
« Back to company indexFATE Chatter Timeline
Stock Ticker for FATE
Most Active Tweeters for FATE
| User | Tweets |
|---|---|
| @AmericanBanking | 4 |
| @stockmktgenius | 3 |
| @firsttomarkets | 2 |
| @ZolmaxNews | 2 |
| @dailypoliticaln | 2 |
Recent Tweets for FATE
 |
@TranscriptDaily Fate Therapeutics $FATE Rating Lowered to Hold at BidaskClub https://t.co/bd89VYUhK9 June 17th 2019, 4:06am |
 |
@registrarjourn Fate Therapeutics $FATE Now Covered by Mizuho https://t.co/3sHvdrdDG8 June 16th 2019, 5:06am |
 |
@EnterpriseLeade Fate Therapeutics $FATE Now Covered by Mizuho https://t.co/QKWpmpZ5v2 June 16th 2019, 5:06am |
 |
@stockmktgenius $FATE Fate Therapeutics, Inc. - #LeaderPullBack Close: 17.83 Liq: $18M https://t.co/MDvZ4cvDIr June 16th 2019, 12:06am |
 |
@AmericanBanking Financial Analysis: Genocea Biosciences $GNCA and Fate Therapeutics $FATE https://t.co/f1FF2ouHjS #stocks June 15th 2019, 8:06pm |
 |
@dailypoliticaln Mizuho Begins Coverage on Fate Therapeutics $FATE https://t.co/ieRmKDKd8I June 15th 2019, 7:06am |
 |
@WKRBNews BidaskClub Downgrades Fate Therapeutics $FATE to Hold https://t.co/GMyvHJqTN4 #markets June 15th 2019, 1:06am |
 |
@OlympiaReport Mizuho Begins Coverage on Fate Therapeutics $FATE https://t.co/3Y2aiXSBCv June 14th 2019, 4:06am |
 |
@TradeFlags TD BUY $FATE at 17.58, Supp 16.02 Resis 20.25 R26 HiLo 74% T1Y 22 strong_buy 1.2 fwdPE -13.7 DIV N/A #Fate Thera… https://t.co/QV1e9PMyIk June 13th 2019, 11:06pm |
|
@stockmktgenius $FATE Fate Therapeutics, Inc. - #LeaderPullBack Close: 17.58 Liq: $14M https://t.co/MDvZ4cvDIr June 13th 2019, 9:06pm |
 |
@ZolmaxNews BidaskClub Lowers Fate Therapeutics $FATE to Hold https://t.co/bRcDK6B63T June 13th 2019, 1:06pm |
 |
@_L_E_U riding $FATE since $16.02, bouncing off that MA180 @mishtix888 @WebullGlobal https://t.co/VQZZjTj51W June 13th 2019, 12:06pm |
 |
@firsttomarkets Fate Therapeutics, Inc. Initiated Coverage by Mizuho (Ranked 36th) to Buy $FATE #FATE https://t.co/4Ftj1ua6Xf June 13th 2019, 10:06am |
 |
@WatchlistN Fate Therapeutics $FATE Now Covered by Analysts at Mizuho https://t.co/Y1JCXdWO5G June 13th 2019, 9:06am |
|
@AmericanBanking Fate Therapeutics Inc $FATE Receives Average Rating of “Buy” from Analysts https://t.co/KJaMx6beQb #stocks June 13th 2019, 2:06am |
|
@ZolmaxNews Fate Therapeutics Inc $FATE Receives Average Recommendation of “Buy” from Brokerages https://t.co/gLnh6MWU03 June 13th 2019, 2:06am |
 |
@Tickeron A.I.dvisor made a bearish call on $FATE, netting in a 12.79% gain over 3 weeks https://t.co/NV7zSxEZZc https://t.co/MWIBthrM55 June 12th 2019, 11:06pm |
|
@AmericanBanking Fate Therapeutics $FATE Receives New Coverage from Analysts at Mizuho https://t.co/vkbrHyP0yA #stocks June 12th 2019, 6:06pm |
 |
@dispatchtribune Fate Therapeutics $FATE Coverage Initiated by Analysts at Mizuho https://t.co/mnF9DBsaeM June 12th 2019, 6:06pm |
 |
@Gambiste1 RT @_B_I_O_T_E_C_H_: MIZUHO $FATE Initiating Coverage with BUY and $27 PT - Transformative Potential, Data in 2019 June 12th 2019, 6:06pm |
 |
@PriceTargetsNet $FATE RATING INITIATED AT MIZUHO SECURITIES USA. https://t.co/rKW5avkrYU June 12th 2019, 4:06pm |
 |
@_B_I_O_T_E_C_H_ MIZUHO $FATE Initiating Coverage with BUY and $27 PT - Transformative Potential, Data in 2019 June 12th 2019, 4:06pm |
 |
@IlliniJJ $FATE, looks like I may have missed getting back in under $16 June 12th 2019, 2:06pm |
 |
@FlynancialA $FATE keeps knocking on the 40 wk SMA (200 day SMA). $XBI https://t.co/IoXlX96FsB June 12th 2019, 9:06am |
 |
@Dadbod4evah Older but interesting ....not all NK r created equal $fate https://t.co/AGNLeMAsxS June 11th 2019, 9:06pm |
 |
@SwingTradeBot Recent $FATE technical alerts: Fell Below 50 DMA plus 6 more alerts... https://t.co/WlSx9Zwpdv June 11th 2019, 3:06pm |
|
@OlympiaReport Fate Therapeutics $FATE Coverage Initiated at Roth Capital https://t.co/LjbPebsLXU June 10th 2019, 3:06am |
|
@TranscriptDaily Fate Therapeutics $FATE Now Covered by Analysts at Roth Capital https://t.co/HECDro5bqf June 9th 2019, 7:06am |
 |
@marc_milam @AndysCycles $fate ! lol June 8th 2019, 2:06pm |
|
@dispatchtribune Fate Therapeutics $FATE Shares Down 7.1% https://t.co/65mG4KLtHu June 8th 2019, 11:06am |
|
@dakotafinancial Fate Therapeutics $FATE Now Covered by Roth Capital https://t.co/Y1MBSBrWuQ June 8th 2019, 9:06am |
|
@AmericanBanking Fate Therapeutics $FATE Now Covered by Roth Capital https://t.co/WlBS1WoC7z #stocks June 7th 2019, 10:06am |
|
@firsttomarkets Fate Therapeutics, Inc. Initiated Coverage by Roth Capital (Ranked 74th) to Neutral with $20PT $FATE #FATE https://t.co/4Ftj1ua6Xf June 7th 2019, 10:06am |
 |
@ConsumerFeed Fate Therapeutics $FATE Earns Neutral Rating from Analysts at Roth Capital https://t.co/6MtWwNnWzQ June 7th 2019, 8:06am |
 |
@Traderideas1 RT @BioStocks: $FATE initiated with a Neutral at Roth. PT $20 June 7th 2019, 6:06am |
 |
@BioStocks $FATE initiated with a Neutral at Roth. PT $20 June 7th 2019, 6:06am |
 |
@TickerReport Comparing Fate Therapeutics $FATE and Spark Therapeutics $ONCE https://t.co/KTSz2FqnXd June 7th 2019, 3:06am |
|
@PriceTargetsNet $FATE RATING INITIATED AT ROTH CAPITAL PARTNERS. https://t.co/rKW5av2QAk June 7th 2019, 12:06am |
 |
@macondailynews Brokerages Expect Fate Therapeutics Inc $FATE Will Post Quarterly Sales of $1.34 Million https://t.co/2fIuA6qcGQ June 6th 2019, 9:06pm |
|
@stockmktgenius $FATE Fate Therapeutics, Inc. - #LeaderPullBack Close: 17.71 Liq: $14M https://t.co/MDvZ4cvDIr June 6th 2019, 6:06pm |
 |
@andyarca $FATE buyout? June 6th 2019, 1:06pm |
 |
@Smallbios1 Wow even $FATE is down almost -10% today .. what’s not getting destroyed ? This seems like a planned attempt to des… https://t.co/IQRRBaXcgK June 6th 2019, 1:06pm |
|
@SwingTradeBot 50 DMA Support today: $FATE $OSN ... https://t.co/aW7zteKP9U June 6th 2019, 11:06am |
 |
@brendan_49 Any specific reason to doubt that $FATE enhanced (for persistence, CD16 expression, and CD16 affinity) NK cells wil… https://t.co/KeSYlPUZzi June 5th 2019, 2:06pm |
|
@dailypoliticaln Spark Therapeutics $ONCE and Fate Therapeutics $FATE Critical Survey https://t.co/7qh87gZX6x June 5th 2019, 2:06am |
 |
@TheMarketsDaily Fate Therapeutics Inc $FATE Expected to Post Earnings of -$0.30 Per Share https://t.co/tU2Htj4teW June 4th 2019, 4:06pm |
 |
@stocknewstimes Brokerages Expect Fate Therapeutics Inc $FATE Will Post Quarterly Sales of $1.34 Million https://t.co/8aWNuDK7WW June 4th 2019, 4:06pm |
 |
@SleekMoneycom Brokerages Expect Fate Therapeutics Inc $FATE Will Post Quarterly Sales of $1.34 Million https://t.co/WCDvhBxQJV #investing June 4th 2019, 4:06pm |
 |
@JRMKE_ @BioEqman You do realize that all the patients being treated for $FATE NK-100 are in the PD stage of their disease… https://t.co/XBmZBgtpJv June 4th 2019, 3:06am |
 |
@TurboResearch @BioEqman @BioValues No haven't looked into $FATE but yes if they show improvement in expansion, persistence and tr… https://t.co/Z49aCrR5jw June 4th 2019, 1:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.